Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2010 08:00 ET | Source: Marshall Edwards, Inc.

Marshall Edwards, Inc. Announces Grants Under Nasdaq Rule 5635

SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - April 29, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHLD), a specialist oncology company focusing on the clinical development of novel anti-cancer...
February 08, 2010 08:00 ET | Source: Marshall Edwards, Inc.

Marshall Edwards, Inc. Announces Resignation of Christopher Naughton From Board of Directors

SYDNEY, AUSTRALIA--(Marketwire - February 8, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL) announced that Christopher Naughton had resigned as a member of the Board of Directors effective February 5,...
January 21, 2010 18:34 ET | Source: Marshall Edwards, Inc.

Analysis of Marshall Edwards, Inc.'s OVATURE Trial to Proceed Following Database Lock

NEW CANAAN, CT--(Marketwire - January 21, 2010) - The Board of Directors of Marshall Edwards, Inc. today advised that analysis of tumor response data from the OVATURE trial will be performed in the...
October 23, 2007 08:05 ET | Source: Novogen

New Data on Novogen Oncology Pipeline to Be Released

SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - October 23, 2007) - New data on the Novogen oncology pipeline compound NV-128 will be presented on October 23 at the annual AACR/EORTC/NCI...
October 22, 2007 19:25 ET | Source: Marshall Edwards, Inc.

Yale Cancer Center Sponsors Study of Phenoxodiol for Prostate Cancer

NEW HAVEN, CT--(Marketwire - October 22, 2007) - Yale researchers have begun recruiting 60 men for a clinical trial investigating an experimental new drug, oral phenoxodiol, as a potential first line...